Department of Respiratory Medicine, National Heart and Lung Institute, Imperial College London, Norfolk Place, London W2 1PG, UK.
Am J Respir Crit Care Med. 2011 Mar 15;183(6):734-42. doi: 10.1164/rccm.201006-0833OC. Epub 2010 Oct 1.
Respiratory virus infections are associated with chronic obstructive pulmonary disease (COPD) exacerbations, but a causative relationship has not been proven. Studies of naturally occurring exacerbations are difficult and the mechanisms linking virus infection to exacerbations are poorly understood. We hypothesized that experimental rhinovirus infection in subjects with COPD would reproduce the features of naturally occurring COPD exacerbations and is a valid model of COPD exacerbations.
To evaluate experimental rhinovirus infection as a model of COPD exacerbation and to investigate the mechanisms of virus-induced exacerbations.
We used experimental rhinovirus infection in 13 subjects with COPD and 13 nonobstructed control subjects to investigate clinical, physiologic, pathologic, and antiviral responses and relationships between virus load and these outcomes.
Clinical data; inflammatory mediators in blood, sputum, and bronchoalveolar lavage; and viral load in nasal lavage, sputum, and bronchoalveolar lavage were measured at baseline and after infection with rhinovirus 16. After rhinovirus infection subjects with COPD developed lower respiratory symptoms, airflow obstruction, and systemic and airway inflammation that were greater and more prolonged compared with the control group. Neutrophil markers in sputum related to clinical outcomes and virus load correlated with inflammatory markers. Virus load was higher and IFN production by bronchoalveolar lavage cells was impaired in the subjects with COPD.
We have developed a new model of COPD exacerbation that strongly supports a causal relationship between rhinovirus infection and COPD exacerbations. Impaired IFN production and neutrophilic inflammation may be important mechanisms in virus-induced COPD exacerbations.
呼吸道病毒感染与慢性阻塞性肺疾病(COPD)加重有关,但尚未证明两者存在因果关系。自然发生的加重事件研究较为困难,病毒感染与加重之间的联系机制也知之甚少。我们假设在 COPD 患者中进行的实验性鼻病毒感染将重现自然发生的 COPD 加重的特征,并且是 COPD 加重的有效模型。
评估实验性鼻病毒感染作为 COPD 加重模型,并研究病毒引起加重的机制。
我们使用 13 名 COPD 患者和 13 名非阻塞性对照者的实验性鼻病毒感染来研究临床、生理、病理和抗病毒反应以及病毒载量与这些结果之间的关系。
在感染鼻病毒 16 前后测量了临床数据;血液、痰和支气管肺泡灌洗液中的炎症介质;以及鼻冲洗、痰和支气管肺泡灌洗液中的病毒载量。在鼻病毒感染后,COPD 患者出现下呼吸道症状、气流阻塞以及全身和气道炎症,与对照组相比,这些症状更为严重且持续时间更长。痰中的中性粒细胞标志物与临床结果和病毒载量相关,与炎症标志物相关。COPD 患者的病毒载量更高,支气管肺泡灌洗液细胞产生 IFN 的能力受损。
我们已经开发出一种新的 COPD 加重模型,该模型强烈支持鼻病毒感染与 COPD 加重之间存在因果关系。IFN 产生受损和中性粒细胞炎症可能是病毒引起的 COPD 加重的重要机制。